Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acorda Therapeutics
(NQ:
ACOR
)
0.6150
+0.0004 (+0.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 21, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acorda Therapeutics
< Previous
1
2
3
4
5
6
Next >
Acorda Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
March 09, 2023
From
Acorda Therapeutics
Via
Business Wire
ESTEVE Launches INBRIJA® in Spain
March 07, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Fourth Quarter/Year End 2022 Update: Webcast/Conference Call Scheduled for March 9, 2023
March 06, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Receives Nasdaq Extension to Meet Minimum Bid Price Requirement
February 14, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics to Present at Sequire Biotechnology Conference
January 31, 2023
From
Acorda Therapeutics
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
January 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 05, 2023
Via
Benzinga
Acorda Therapeutics Announces New Agreement with Catalent for Long-Term Global Supply of INBRIJA®
January 05, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Announces Revised Long-Term Financial Guidance
December 22, 2022
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Receives Nasdaq Listing Determination Letter and Plans to Request a Hearing
December 20, 2022
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Makes December 2022 $6.2 Million Interest Payment on Secured Debt in Cash
December 05, 2022
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Announces Passage of Reverse Stock Split Proposal at its Special Meeting of Stockholders
November 11, 2022
From
Acorda Therapeutics
Via
Business Wire
How Is The Market Feeling About Acorda Therapeutics?
November 09, 2022
Acorda Therapeutics's (NASDAQ:ACOR) short percent of float has risen 230.3% since its last report. The company recently reported that it has 792 thousand shares sold short, which is 3.27% of all...
Via
Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
Gainers
Via
Benzinga
Acorda Therapeutics Announces Adjournment of Special Meeting of Stockholders
November 04, 2022
From
Acorda Therapeutics
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 02, 2022
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.
Via
Benzinga
Acorda Therapeutics Reports Third Quarter 2022 Financial Results
November 01, 2022
From
Acorda Therapeutics
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 01, 2022
Gainers
Via
Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
November 02, 2022
Gainers
Via
Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
November 01, 2022
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 01, 2022
Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
Via
InvestorPlace
Why Goodyear Tire & Rubber Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
November 01, 2022
Gainers Quotient Limited (NASDAQ: QTNT) rose 60.7% to $0.1295 in pre-market trading. Quotient shares dipped 37% on Monday after the company announced a 1-for-40 reverse stock split.
Via
Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
November 01, 2022
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 31, 2022
Gainers
Via
Benzinga
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
October 28, 2022
Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 27, 2022
Gainers
Via
Benzinga
Why UserTesting Shares Are Trading Higher By Around 93%? Here Are 53 Stocks Moving In Thursday's Mid-Day Session
October 27, 2022
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 111% to $2.03 after the company announced it entered into a license agreement with Transcosmos Digital Technology for its Apromore process...
Via
Benzinga
Acorda Therapeutics Provides Long-Term Business Plan and Financial Guidance
October 27, 2022
From
Acorda Therapeutics
Via
Business Wire
Acorda Third Quarter 2022 Update: Webcast/Conference Call Scheduled for November 1, 2022
October 25, 2022
From
Acorda Therapeutics
Via
Business Wire
Acorda Shareholders Invited to Virtual Q&A with CEO Ron Cohen, M.D.
October 21, 2022
From
Acorda Therapeutics
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.